AI patient management company Current Health disclosed on Tuesday the completion of USD11.5m under its Series A funding round led by MMC Ventures.
Legal & General, the FTSE 100 life insurer, is Current Health's first corporate investor and the largest investor in the round. Additionally, Par Equity and Scottish Investment Bank, the investment arm of Scottish Enterprise, participated in this round.
The capital will be used by Current Health to scale its patient management platform, with the goal of preventing illness for one million patients around the world by 2021. It uses wearable and wireless vital signs monitoring, clinical indicators from an ecosystem of more than 50 integrations and symptoms collected via its patient engagement tools, to continuously track patient health trends.
Under the next stage of its growth, the company will open a US headquarters in New York City as well as appointed Richard Lennox as its new COO and Sean Ginney as VP of Sales.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar